The Role of Language in Trial Participation

Language shapes how participants understand a study. That may sound obvious, but it is often underestimated in practice. When trial materials are reviewed, most of the attention goes to regulatory accuracy, not emotional clarity. Yet the words used in eConsent, instructions, app messages and support emails have a direct effect on how comfortable participants feel and how likely they are to stay involved.

‍

There is a difference between “accurate” and “understandable.” Telling a participant they may experience a “mild to moderate gastrointestinal disturbance” is not the same as saying “you might feel bloated or have an upset stomach.” Both are valid. But only one matches how people naturally talk - and think - about their health.

‍

It is not just about tone. The structure of a sentence can shift how participants interpret responsibility. For example:

• “You must complete this form each day to remain in the study” can feel like a threat.
• “This form helps us understand your experience. If you can complete it each day, that would be very helpful” invites cooperation.

‍

The first is rigid. The second is collaborative. This matters, especially in digital trials, where tone replaces face-to-face reassurance.

‍

Small changes in language often carry large effects. Let’s take some common examples:

• eConsent screens that say “click to acknowledge” instead of “click to confirm you’ve understood” shift the focus from passive receipt to active engagement.
• Reminder notifications that say “you missed your diary entry again” sound accusatory. “Your diary entry is ready whenever you are” maintains the invitation without pressure.
• Survey questions with jargon like “adverse event” may be misunderstood. Using terms like “unexpected symptom” makes more sense to non-clinical users.

‍

In longer studies, repetition can create its own problems. Participants start to tune out messages that feel generic or robotic. A notification that always says “task due today” eventually becomes noise. A small variation, like “time for your Day 14 check-in” or “quick update needed before tomorrow,” can help keep attention.

‍

This doesn’t mean trial communications need to be overly casual. It just means they should reflect how real people read, decide and respond—especially when dealing with health-related tasks.

‍

When participants feel like the trial is speaking to them, not at them, their behaviour changes. They are more likely to complete tasks, ask questions and report accurately. They also feel more respected, which makes a difference in how they talk about the study to others and how willing they are to stay involved when things get difficult.

‍

Language is not just a compliance tool. It is a trust-building mechanism. And in decentralised studies where human contact is reduced, the way we write may be the most human thing left.